Navigation Links

Biology Technology

American Brain Tumor Association Seeks Innovative Concepts For Discovery Research Grants

9/1/2015
CHICAGO , Sept. 1, 2015 The American Brain Tumor Association (ABTA) is now accepting Letters of Intent (LOI) for its Discovery Research Grant program. LOIs are due no later than Wednesday, October 7, 2015 at 12:00 noon CDT. Discovery Grants are one-year, $50,000 grants that fund high risk/high impact projects with the potential to change current diagnostic o... [Comments]

ContraVir to Present at Rodman & Renshaw 17th Annual Global Investment Conference

9/1/2015
EDISON, N.J. , Sept. 1, 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it will present at the Rodman & Renshaw 17 th Annual Global Investment Conference sponsored by H.C. Wainwright & Co. taking place September 8-10, 2015 at... [Comments]

September Is Prostate Cancer Awareness Month

9/1/2015
NEW YORK , Sept. 1, 2015 Prostate cancer is the second leading cause of cancer death in American men. One in seven men will be diagnosed with prostate cancer and 233,000 new cases are diagnosed annually. That said, not every diagnosis warrants intervention. Mount experts are using a powerful new technique, MRI Fusion Biopsy, to more accurate... [Comments]

ImageXpress Micro Confocal High-Content Imaging System Expands the Boundaries of Research

9/1/2015
Sunnyvale, CA (PRWEB) September 01, 2015 Molecular Devices today announced the launch of the new ImageXpress® Micro Confocal High-Content Imaging System. This transformative system fits a broad range of automated cell-based imaging applications, especially emerging assays that use 3D cel... [Comments]

Alexi Venice’s Debut Novel Takes on the Human Testing of a Vaccine for Ebola and Revenge by an Anti-Big Pharma Terrorist Group in ‘Ebola Vaccine Wars'

9/1/2015
Eau Claire, WI (PRWEB) September 01, 2015 In her thought provoking debut novel ‘ Ebola Vaccine Wars ’ (eBookIt.com; August 2015), Alexi Venice expertly transports the reader to a not-so-distant future faced with an Ebola pandemic that is on the cusp of wiping out humanity. Venice introduces P... [Comments]

AxioMx Announces Receipt of SBIR Grant for DNA-Protein Complex Antigen Development

9/1/2015
Branford, Conn. (PRWEB) September 01, 2015 AxioMx Inc. , a leader in the development of high-quality recombinant antibodies, announced today that the National Institutes of Health (NIH) has awarded the company a Phase I Small Business Innovation Research (SBIR) grant (1R41DK104602-01), which... [Comments]

VetStem Biopharma Announces New Clinical Research Program for Equine Cervical Facet Joint Disease

9/1/2015
Poway, CA (PRWEB) September 01, 2015 VetStem Biopharma announces new Clinical Research program for Equine Cervical Facet joint disease. Equine cervical facet joint problems can be caused by injuries and abnormalities of the cervical spine. Arthritic cervical facet joints gradually enlarge... [Comments]

Dohmen Life Science Services Appoints Eric Floyd, Ph.D. as Chief Science Officer

9/1/2015
MILWAUKEE , Sept. 1, 2015 The Dohmen Company today announced the appointment of Eric Floyd , Ph.D., MBA as Chief Science Officer (CSO) of Dohmen Life Science Services (DLSS).  In this newly created role, Dr. Floyd will lead Dohmen's growing regulatory consulting practice as well as a portfolio of pre-commercial and post approval outsourced services in quality, regulatory... [Comments]

Neuro Advance Boston Brings Together Leading Neuroscience Experts on October 14 at Harvard Medical School

9/1/2015
Boston, MA (PRWEB) September 01, 2015 Leading CEOs, CSOs, CMOs, and heads of neuro from top biopharmaceutical companies in the neuro and pain management space join prominent academics and key investors for Neuro Advance Boston, October 14, 2015 at the Joseph B. Martin Conference Center at Har... [Comments]

New White Paper Explores Data Lake Opportunities in the Healthcare Industry

9/1/2015
Warren, NJ (PRWEB) September 01, 2015 Knowledgent , the data and analytics firm, today announced a new white paper that highlights the opportunities for advanced analytics utilizing data lakes in the healthcare industry. As the Internet of Things (IoT) continues to grab headlines across... [Comments]

Medfusion Secures Funding to Continue Evolution and Advance Mobile Strategy

9/1/2015
CARY, N.C. , Sept. 1, 2015   Medfusion, Inc., a patient engagement platform dedicated to facilitating the relationship between doctors and patients, today announced a $3 million investment from two Durham, N.C. -based venture capital firms.   "We welcome the financial strength and business association with Bull City Venture Partners and Hatteras Venture Partners... [Comments]

Medicine Technology

Keratoconus Market Clinical Trials Review H2 2015 Global Research Report

9/1/2015
PUNE, India , September 2, 2015 The latest clinical trial report on Keratoconus market for global clinical trials review of H2, 2015 provides an overview of Keratoconus clinical trials scenario with an objective to enhance decision making capabilities of active stakeholders in the market. Complete report on Keratoconus market clinical trials review spread across 72 pages,... [Comments]

Robbins Arroyo LLP Is Investigating the Officers and Directors of ConforMIS, Inc. (CFMS) on Behalf of Shareholders

9/1/2015
SAN DIEGO and BEDFORD, Mass. , Sept. 1, 2015  Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of ConforMIS, Inc. (NASDAQGS: CFMS) violated the Securities and Exchange Act of 1934.  ConforMIS is a medical technology company that uses its iFit Image-to-Implant technology platform to develop, manufacture, and s... [Comments]

Pope McGlamry: Omnibus order in Conserve Hips MDL-2329 sets stage for bellwether trial

9/1/2015
ATLANTA , Sept. 1, 2015 On August 31, 2015, United States District Judge William S. Duffey, Jr. , issued a 123-page order in the first of the consolidated MDL cases alleging that the Wright Medical Conserve metal-on-metal hip replacement devices are defective.[1]  The Court denied the motion for summary judgment as to Plaintiff Robyn Christiansen's claims for defectiv... [Comments]

Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs

9/1/2015
THOUSAND OAKS, Calif. , Sept. 1, 2015  Amgen (NASDAQ: AMGN ) today announced a neuroscience collaboration with Novartis in the areas of Alzheimer's disease and migraine. The collaboration accelerates Amgen's potential entry into Alzheimer's disease by teaming up with Novartis on a differentiated and genetically validated Alzheimer's disease program directed at genetically... [Comments]

Invion Announces Private Placement to US Institutional Investor

9/1/2015
BRISBANE, Australia and Delaware , United States , Sept. 1, 2015 Invion Limited (ASX: IVX; "Company" or "Invion"), is pleased to announce that it has entered into definitive agreements to issue the following securities to an institutional investor in the United States in a private placement for aggregate gross proceeds of approximately A$1.001 million ("Placement")... [Comments]

AccuTec Blades, Inc. Announces Acquisition of Industrial Blades Division from Edgewell Personal Care Company

9/1/2015
VERONA, Va. , Sept. 1, 2015  AccuTec Blades, Inc. today announced the acquisition of Edgewell Personal Care Company's (EPC) Industrial Blades division.  EPC announced in May 2015 its intent to discontinue its industrial blade operations in Verona, Virginia and Obregon, Mexico . Today's announcement marks the completion of the sale process. Rick Gagliano , t... [Comments]

Nevro Announces Submission of Preliminary Response to the Patent Trial and Appeals Board

9/1/2015
MENLO PARK, Calif. , Sept. 1, 2015 Nevro Corp. (NYSE: NVRO ), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that the company has submitted its preliminary response to the Patent Trial and Appeals Board (PTAB) in response to two petitions for inter partes review (IPR), filed by a... [Comments]

HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd.

9/1/2015
FRAMINGHAM, Mass. and OR YEHUDA, Israel , Sept. 1, 2015   HeartWare International, Inc . (Nasdaq: HTWR ), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, announced today that it has entered into a definitive agreement to acquire Valtech Cardio, Ltd . ("Valtech").... [Comments]

Ardelyx Regains NaP2b Program from Sanofi

9/1/2015
FREMONT, Calif. , Sept. 1, 2015 Ardelyx, Inc. (NASDAQ: ARDX ), a clinical-stage biopharmaceutical company focused on gastrointestinal and cardio-renal diseases, today announced that Sanofi notified Ardelyx of its termination of the option and license agreement for Ardelyx's portfolio of NaP2b inhibitors effective September 30, 2015. There was no payment associated with termin... [Comments]

Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide

9/1/2015
THOUSAND OAKS, Calif. and BRUSSELS , Sept. 1, 2015  Amgen (NASDAQ: AMGN ) and UCB (Euronext Brussels: UCB) today announced top-line results from the STRUCTURE trial (STudy evaluating effect of RomosozUmab Compared with Teriparatide in postmenopaUsal women with osteoporosis at high risk for fracture pReviously treated with bisphosphonatE therapy). The study (NCT0179630... [Comments]

NOWDiagnostics Inc. Acquires Canada's ZBx Corporation

9/1/2015
SPRINGDALE, Ark. , Sept. 1, 2015 NOWDiagnostics Inc., based in Springdale, Ark. , recently completed its acquisition of ZBx Corporation of Canada , a move that brings the company closer to its vision of a world where people have greater access to information concerning their health. NOWDiagnostics manufactures and sells a line of unique blood-based rapid tests... [Comments]

(Date:9/1/2015)... , ... September 01, 2015 , ... ... recombinant antibodies, announced today that the National Institutes of Health (NIH) has awarded ... will be administered by the NIH’s National Institute of Diabetes and Digestive and ...
(Date:9/1/2015)... ... September 01, 2015 , ... Leading ... neuro and pain management space join prominent academics and key investors for Neuro ... Harvard Medical School in Boston. , Neuro Advance Boston focuses on the ...
(Date:9/1/2015)... ... September 01, 2015 , ... Industry leader iLab ... Pacific. In this newly-created position, Gibbs will lead iLab’s business operations in the ... of tools. This entails not only introducing iLab to potential partners but support ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... of a groundbreaking new version of its flagship DNA design platform, which has ... complex DNA sequences into numerous genetic parts, which in turn can be recombined ...
Breaking Biology Technology:AxioMx Announces Receipt of SBIR Grant for DNA-Protein Complex Antigen Development 2AxioMx Announces Receipt of SBIR Grant for DNA-Protein Complex Antigen Development 3Neuro Advance Boston Brings Together Leading Neuroscience Experts on October 14 at Harvard Medical School 2iLab Solutions Hires Gerard Gibbs, Director of Business Development, Asia Pacific 2iLab Solutions Hires Gerard Gibbs, Director of Business Development, Asia Pacific 3GenoCAD Releases Combinatorial Design Tool to Optimize Protein Expression and Streamline DNA Synthesis Orders 2
... July 21, 2011 The U.S. Food & Drug ... a clinical trial for gene therapy for a rare ... and London, this trial based on preclinical research performed ... gene therapy product, is now going to be launched ...
... July 21, 2011 Advanced Cell Technology, Inc. ("ACT"; ... medicine, announced today that it has entered into an ... Biotech"), a leading South Korea-based biotechnology company, designed to ... venture, Stem Cell & Regenerative Medicine International (SCRMI).  Under ...
... DURHAM, N.C. Researchers at Duke University Medical Center ... of Chlamydia , the bacteria responsible for the ... States. The team, which included Duke University ... the bacteria,s self-defense mechanisms. The therapies that ...
Cached Biology Technology:Genethon and Children's Hospital Boston Get FDA approval for a Wiskott Aldrich Gene Therapy Trial 2Genethon and Children's Hospital Boston Get FDA approval for a Wiskott Aldrich Gene Therapy Trial 3Genethon and Children's Hospital Boston Get FDA approval for a Wiskott Aldrich Gene Therapy Trial 4Genethon and Children's Hospital Boston Get FDA approval for a Wiskott Aldrich Gene Therapy Trial 5ACT Obtains Exclusive License for Hemangioblast Technology in North America 2ACT Obtains Exclusive License for Hemangioblast Technology in North America 3ACT Obtains Exclusive License for Hemangioblast Technology in North America 4ACT Obtains Exclusive License for Hemangioblast Technology in North America 5Newly designed molecule blocks chlamydia bacteria 2Newly designed molecule blocks chlamydia bacteria 3
(Date:9/1/2015)... Sept. 1, 2015  AccuTec Blades, Inc. today announced ... Blades division.  EPC announced in May 2015 its intent ... Verona, Virginia and Obregon, Mexico ... sale process. Rick Gagliano , ... Blades said, "Our new name, AccuTec Blades, reflects the ...
(Date:9/1/2015)... --NOWDiagnostics Inc., based in Springdale, Ark. , ... Canada , a move that brings the company ... have greater access to information concerning their health. ... blood-based rapid tests that allow health care providers to ... ailments and diseases. ZBx Corporation, a Toronto ...
(Date:9/1/2015)... DALLAS , Sept. 1, 2015 UT ... and distinguished faculty members joined U.S. Representatives ... in a roundtable discussion on the 21 st ... biomedical research currently being considered by the ... faculty – including National Academy of Sciences members, department ...
Breaking Medicine Technology:AccuTec Blades, Inc. Announces Acquisition of Industrial Blades Division from Edgewell Personal Care Company 2NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 2NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 3U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 2U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 3U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 4U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 5
... Conn., May 15, 2012 /PRNewswire-iReach/ -- Global ... important Cambridge Healthtech Institute conferences: IMVACS – ... August 13 – 15, Cambridge, MA - The ... under one heading: the Seventh Annual Novel Vaccines, Design ...
... Labs, Inc. (OTCQB/OTCBB: GOVX), a biotechnology company that creates, ... results for the three months ended March 31, 2012 ... delighted with recent developments that have strengthened and advanced ... David Dodd. "Our Phase 1/2 therapeutic vaccine trial continues ...
Cached Medicine Technology:Attendees Save up to $350 on CHI Conferences This Summer by Registering Through Global Information 2GeoVax Labs Reports 2012 First Quarter Financial Results 2GeoVax Labs Reports 2012 First Quarter Financial Results 3GeoVax Labs Reports 2012 First Quarter Financial Results 4GeoVax Labs Reports 2012 First Quarter Financial Results 5GeoVax Labs Reports 2012 First Quarter Financial Results 6